Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aravind Kancharla
Institution:
The University of Texas at San Antonio Health Science Center
Observed institutions:
The University of Texas at San Antonio Health Science Center,
GentiBio (United States),
The University of Texas at San Antonio
ORCID:
0000-0001-9095-7735
Observed ORCID:
0000-0001-9095-7735
OpenAlex ID:
A5027306509
Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy
2021
·
Deyi Zhang
, Ryan M. Reyes
, et al.
·
Cancer Medicine
·
48
PDF
Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice
2022
·
Myrna G. Garcia
, Yilun Deng
, et al.
·
Aging and Cancer
·
30
PDF
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
2021
·
Ryan Michael Reyes
, Yilun Deng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
22
PDF
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy
2024
·
Ritika Tewari
, Soo Jung Yang
, et al.
·
Journal of Autoimmunity
·
18
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
2023
·
Haiyan Bai
, Alvaro S Padron
, et al.
·
Journal for ImmunoTherapy of Cancer
·
13
PDF
The Role of MicroRNA-155 in Chlamydia muridarum Infected lungs
2020
·
Jonathon Keck
, James P. Chambers
, et al.
·
Microbes and Infection
·
7
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling
2025
·
Carlos O. Ontiveros
, Myrna G. Garcia
, et al.
·
Nature Communications
·
6
PDF
Tumor-intrinsic PD-L1 reduces actin cytoskeleton polymerization to promote mTORC1 signals driving tumor stemness
2019
·
Suresh Chandra Kari
, Aravind Kancharla
, et al.
·
The Journal of Immunology
·
2
690 CD122-selective IL-2 complexes treat ovarian carcinomas, induce Treg fragility and promote T cell stem cells
2020
·
Yilun Deng
, Justin Drerup
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer
2020
·
Ryan Reyes
, Yilun Deng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors
2026
·
Gopal Naik Nenavath
, Diana Gataulin
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
234 Distinct efficacy and immunological responses to αPD-1, αPD-L1 and αPD-L2 immunotherapy in aged versus young hosts
2021
·
Yilun Deng
, Harshita Gupta
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
786 Distinct efficacy and immunological responses to aPD-1, aPD-L1 and aPD-L2 immunotherapy in B16 melanoma in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences
2020
·
Myrna Garcia
, Alvaro Padron
, et al.
·
Journal for ImmunoTherapy of Cancer
4579 Distinct clinical and immunological responses to αPD-1, kαPD-L1 and αPD-L2 immunotherapy in B16 melanoma in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences
2020
·
Myrna G Garcia
, Alvaro Padron
, et al.
·
Journal of Clinical and Translational Science
PDF
Distinct responses to αPD-1, αPD-L1 and αPD-L2 immunotherapy in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences
2020
·
Myrna G Garcia
, Alvaro S Padron
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
15
Citation count:
148
H-index:
6
I10-index:
5
Year
Topic
Type